Overjet Expands Enterprise AI Platform Across Major DSOs, Surpasses 100 Million Dental Image Analyses

Overjet Expands Enterprise AI Platform Across Major DSOs, Surpasses 100 Million Dental Image Analyses

Overjet, the Boston-based dental AI company that became the first to receive FDA clearance for dental AI analysis software, continues to aggressively expand its footprint across the dental service organization landscape. The company, which has now analyzed over 100 million dental images using its artificial intelligence platform, has cemented its position as one of the most widely deployed AI solutions in dentistry, with its technology now integrated into the workflows of some of the largest DSOs in North America.

From FDA Clearance to Enterprise Scale

Overjet’s trajectory has been one of the most closely watched in dental technology. After securing FDA 510(k) clearance for its radiograph analysis platform — a milestone that gave the company a significant regulatory moat — Overjet moved quickly to embed its AI into clinical workflows at scale. The company’s platform uses deep learning to detect and quantify dental conditions including caries, bone loss, and calculus on both periapical and bitewing radiographs, providing dentists with objective, quantitative overlays directly on their existing imaging software.

The company’s dual strategy of serving both dental insurance payers and clinical providers has proven to be a powerful growth engine. On the payer side, Overjet’s AI is used by major dental insurers including Guardian Life, Delta Dental affiliates, and other carriers to automate claims review and reduce processing times. On the clinical side, the enterprise deployment across DSOs has accelerated rapidly, driven by growing demand for AI-assisted diagnostic support and quality assurance tools.

DSOs Driving Adoption at Scale

The partnership between Overjet and Heartland Dental, one of the nation’s largest DSOs with over 1,800 supported offices, marked a landmark moment for AI adoption in the DSO space. The deployment brought FDA-cleared AI-assisted radiograph analysis to thousands of dental professionals in a single enterprise rollout, demonstrating the scalability that DSOs can bring to health technology adoption. Heartland Dental’s network serves millions of patients annually, meaning the impact of AI-assisted diagnostics at this scale is substantial.

“The deployment of AI across large dental organizations represents a fundamental shift in how diagnostic support is delivered. When a single technology partner can reach thousands of operatories through one DSO relationship, the impact on patient care is exponential.”

— Industry analyst commentary on DSO-driven AI adoption

Beyond Heartland Dental, Overjet has built relationships with multiple DSO partners and group practices. The company’s integration approach — working within existing practice management and imaging platforms rather than requiring new hardware — has reduced friction for large-scale rollouts. Overjet integrates with widely used dental imaging systems, making deployment across hundreds or thousands of locations significantly more feasible than solutions requiring dedicated equipment.

The Competitive Landscape Intensifies

Overjet is not alone in pursuing the DSO market. Pearl, another FDA-cleared dental AI company, has been building its own partnerships with DSOs and group practices through its Second Opinion platform, which provides real-time AI analysis of dental radiographs. VideaHealth, backed by significant venture funding, has similarly targeted large group practices with its AI-powered caries detection and treatment planning tools. The competition has intensified as all three companies vie for exclusive or preferred vendor status with the largest DSOs.

What distinguishes the current phase of dental AI deployment from earlier pilot programs is the shift from proof-of-concept to enterprise commitment. DSOs are no longer merely testing AI in a handful of offices — they are writing it into their standard clinical protocols and technology stacks. This transition carries significant implications for clinical governance, as AI-assisted diagnostics become part of the standard of care within these organizations.

What This Means for the Industry

The rapid expansion of AI across DSO networks signals several important trends for the broader dental industry:

• Standardization of AI diagnostics: As DSOs adopt AI across their entire networks, AI-assisted analysis is moving from a competitive differentiator to a baseline expectation in organized dentistry.
• Data network effects: Companies like Overjet, processing over 100 million images, gain compounding advantages as larger datasets improve model accuracy and expand the range of detectable conditions.
• Payer-provider alignment: Overjet’s unique position serving both insurance companies and clinical practices creates a feedback loop that could reshape how claims are submitted, reviewed, and adjudicated.
• Regulatory precedent: Each new FDA clearance and each large-scale deployment creates a stronger foundation for AI as an accepted component of dental diagnostics, influencing future regulatory frameworks.

As Overjet and its competitors continue to expand, the dental AI market is entering a new phase defined not by the novelty of the technology, but by the operational realities of enterprise deployment. For DSO executives evaluating their technology strategy, the question is no longer whether to adopt AI, but which platform to standardize on — and how quickly they can get there.

DSO News will continue to track enterprise AI deployments across major dental service organizations. Have a tip about a new partnership or rollout? Contact our editorial team.